First six months of top-line data from Radius Health’s ACTIVExtend show that treatment with investigational drug abaloparatide-SC followed by alendronate provides important clinical benefit with reductions in new vertebral, non-vertebral and clinical osteoporotic fractures

ICON and IBM plan to revolutionize clinical trial feasibility, patient recruitment and study start-up timelines

Scripps Florida scientists’ structural discoveries could aid in better drug design

Asterias announces preclinical data supporting the safety and use of AST-OPC1 as a treatment for spinal cord injury

Company unveils clinical and immunological outcomes in patients with brain metastases

Company’s lead molecule, SDP051, is a Cadherin-11 inhibitor based on a pioneering cell technology and has completed Phase 1 of clinical development

GeneWEAVE’s Smarticles technology enhances Roche’s diagnostics role in fighting drug-resistant bacteria

Move is driven in large part by pressure on pharmas and biotechs to do more regulatory work even as budgets tighten

VBI Vaccines announces development of a novel glioblastoma immunotherapy candidate to be evaluated at Columbia’s Brain Tumor Center

Finding the long sought- after mediator of mTORC1 activation by leucine opens up opportunities for creating new medicines for metabolic, musculoskeletal, autoimmune and other age- related diseases

Chimerix presents preliminary data on brincidofovir in liver transplant recipients with adenovirus infections at IDWeek in San Diego

Nanoparticulate carbon black particles are tiny culprits that start emphysema